{"nctId":"NCT04590404","briefTitle":"Metabolism Informed Smoking Treatment: The MIST RCT","startDateStruct":{"date":"2020-11-17","type":"ACTUAL"},"conditions":["Smoking"],"count":606,"armGroups":[{"label":"MIST (Metabolism-Informed Smoking Treatment)","type":"EXPERIMENTAL","interventionNames":["Behavioral: Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.","Drug: Nicotine Replacement Therapy","Drug: Varenicline","Other: Metabolism Informed Smoking Treatment (Nicotine metabolite ratio (NMR)-based selection of pharmacotherapy)"]},{"label":"Usual Care","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.","Drug: Nicotine Replacement Therapy","Drug: Varenicline"]}],"interventions":[{"name":"Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.","otherNames":[]},{"name":"Nicotine Replacement Therapy","otherNames":[]},{"name":"Varenicline","otherNames":["Chantix"]},{"name":"Metabolism Informed Smoking Treatment (Nicotine metabolite ratio (NMR)-based selection of pharmacotherapy)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* be 18 years or older\n* be enrolled in an insurance plan that supports prescription coverage for smoking cessation medication (such as Medicare part D, Medicaid, or private insurance) to facilitate bedside delivery of medications prior to hospital discharge\n* have a regular provider/PCP\n* agree to quit or try to quit smoking upon hospital discharge\n* be a daily smoker when smoking normally during the month prior to entering the hospital\n* be medically eligible to use varenicline\n* be medically eligible to use nicotine replacement therapy\n* have received discharge medication recommendations from a tobacco counselor\n* agree to take smoking cessation medication (i.e., varenicline OR nicotine replacement therapy) home and consider using it\n* have a cell phone or landline that can be reached directly (i.e., without transfer)\n* have a permanent address where they live and can receive mail\n* estimated life expectancy of at least one year or greater\n\nExclusion Criteria:\n\n* insufficient time to perform and complete the enrollment process\n* barrier to effective communication (including low English proficiency)\n* not cognitively able to participate in the study\n* too ill, on hospice, or physically unable to participate in the follow-up process\n* previously completed the MIST study or is currently enrolled in a quit smoking study that involves a medication-based treatment\n* estimated life expectancy of less than one year","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Biochemically-validated Past 7-day Point Prevalence Tobacco Abstinence","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"54","spread":null},{"groupId":"OG001","value":"49","spread":null}]}]}]},{"type":"SECONDARY","title":"Biochemically-validated Past 7-day Point Prevalence Tobacco Abstinence","description":null,"classes":[]},{"type":"SECONDARY","title":"Self-reported Medication Adherence Over the Past 7 Days","description":null,"classes":[]},{"type":"SECONDARY","title":"Self-reported Receipt of Prescription for Smoking Cessation Medication Subsequent to the Initial Study Medication Prescription","description":null,"classes":[]},{"type":"SECONDARY","title":"[Exploratory] Healthcare Composite Outcome Consisting of Hospitalization, Emergency Department Visit, and/or Death Within 12 Months","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":140,"n":294},"commonTop":["Insomnia","Fatigue","Restlessness","Anxiety (includes nervousness and panic attacks)","Agitation and/or irritability"]}}}